Heart failure & cardiomyopathies

Multimarker Analysis of Serially Measured GDF-15, NT-proBNP, ST2, GAL-3, cTnI, Creatinine, and Prognosis in Acute Heart Failure

Circ Heart FailPublished Prospective cohort study

Authors' conclusion

Sequentially measured GDF-15 independently and dynamically predicts risk of adverse outcomes during 1-year follow-up after index admission for acute HF. NT-proBNP remains a robust predictor among potential candidates.

Study context

Population
Patients with acute heart failure (HF), 14 hospitals in the Netherlands, 2009–2014
Participants
496 patients
Outcome
Composite of:
  • All-cause mortality
  • HF rehospitalization
Follow-up
1-year follow-up
Methodological detailsmulticentre, 14 hospitals in the Netherlands, serial biomarker measurements, multivariable joint modeling, Blood sampling scheduled at 7 moments during 1-year follow-up; biomarkers measured in a central laboratory
  • Multicentre
  • 14 hospitals in the Netherlands
  • Serial biomarker measurements
  • Multivariable joint modeling
  • Blood sampling scheduled at 7 moments during 1-year follow-up; biomarkers measured in a central laboratory

Main finding

As reported in the abstract

GDF-15 (per 1 SD log)Hazard ratio (95% CI)
Unadjusted
2.14(1.78–2.57)
Adjusted for clinical confounders
1.96(1.49–2.53)
Jointly modeled with all biomarkers
1.44(1.05–1.91)

Per 1 SD log, as printed

Primary end point reached
188 (40%)

Observational data: associations, not effects.

Further findings

Primary end point by serial NT-proBNP

HR (CI)
NT-proBNPAdjusted for clinical confounders2.38 (1.78–3.33)
NT-proBNPJointly modeled with all biomarkers1.52 (1.15–2.08)

Risk discrimination of multimarker model (GDF-15, NT-proBNP, troponin I)

AUC
0.785

Baseline characteristics · median baseline

Median age, years
74
Women
37%
Median baseline GDF-15, pg/mL
4632

Original publication

Multimarker Analysis of Serially Measured GDF-15, NT-proBNP, ST2, GAL-3, cTnI, Creatinine, and Prognosis in Acute Heart Failure. Circ Heart Fail. Published 21 November 2022. doi:10.1161/circheartfailure.122.009526

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.